Healthcare provider profile · identity verified

Canh Tran, MD

Hospitalist · STAR LAKE, NY · NPI 1740674191

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	351	94
Levothyroxine Sodium	Levothyroxine Sodium	229	54
Amlodipine Besylate	Amlodipine Besylate	219	66
Lisinopril	Lisinopril	169	51
Omeprazole	Omeprazole	160	44
Famotidine	Famotidine	157	41
Metoprolol Succinate	Metoprolol Succinate	143	38
Gabapentin	Gabapentin	134	37
Losartan Potassium	Losartan Potassium	133	38
Hydrochlorothiazide	Hydrochlorothiazide	113	35
Rosuvastatin Calcium	Rosuvastatin Calcium	105	26
Metformin Hcl	Metformin Hcl	100	31
Tamsulosin Hcl	Tamsulosin Hcl	81	26
Pantoprazole Sodium	Pantoprazole Sodium	71	23
Albuterol Sulfate Hfa	Albuterol Sulfate	66	18
Furosemide	Furosemide	64	21
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	58	58
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	58	58
Allopurinol	Allopurinol	57	17
Escitalopram Oxalate	Escitalopram Oxalate	57	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	15
Spironolactone	Spironolactone	50	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	49	41
Buspirone Hcl	Buspirone Hcl	46	suppressed
Potassium Chloride	Potassium Chloride	45	17
Ozempic	Semaglutide	44	suppressed
Prednisone	Prednisone	44	12
Trazodone Hcl	Trazodone Hcl	43	13
Citalopram Hbr	Citalopram Hydrobromide	41	15
Pravastatin Sodium	Pravastatin Sodium	41	16
Meloxicam	Meloxicam	40	15
Metoprolol Tartrate	Metoprolol Tartrate	40	12
Finasteride	Finasteride	39	12
Tramadol Hcl	Tramadol Hcl	39	14
Simvastatin	Simvastatin	38	13
Sertraline Hcl	Sertraline Hcl	37	13
Eliquis	Apixaban	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	14
Atenolol	Atenolol	34	11
Fluticasone Propionate	Fluticasone Propionate	30	16
Januvia	Sitagliptin Phosphate	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	17
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ramipril	Ramipril	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	13
Gemfibrozil	Gemfibrozil	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Glipizide Er	Glipizide	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error